ADHD prescription startup Done pivoting to in-person care following DEA rule change

The startup is changing its business model that garnered controversy over reports it was over prescribing controlled substances.

Source: bizjournals.com Health Care:Biotechnology headlines - April 20, 2023 Category: Biotechnology Authors: William Hicks Source Type: news